Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

NRX Pharmaceuticals (NRXP) Other Gross PP&E Adjustments (2024 - 2025)

NRX Pharmaceuticals (NRXP) has disclosed Other Gross PP&E Adjustments for 2 consecutive years, with -$4.6 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments fell 23.9% to -$4.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.6 million through Dec 2025, down 23.9% year-over-year, with the annual reading at -$4.6 million for FY2025, 23.9% down from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was -$4.6 million at NRX Pharmaceuticals, down from -$4.2 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was -$2.8 million in Q1 2024, with the low at -$4.6 million in Q4 2025.